Logo for Kronos Bio Inc

Kronos Bio Investor Relations Material

Latest events

Logo for Kronos Bio Inc

Status Update

Kronos Bio
Logo for Kronos Bio

Q1 2025

23 Jul, 2025
Logo for Kronos Bio

Q4 2024

17 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Kronos Bio Inc

Access all reports
Kronos Bio Inc. is a U.S.-based biotechnology company focused on the discovery and development of therapies for cancer and other serious diseases. The company specializes in targeting dysregulated transcription factors and other key regulatory proteins involved in disease progression. Using its proprietary drug discovery platform, Kronos Bio aims to develop small-molecule therapies that address unmet medical needs. Its research spans early discovery through clinical development. The company is headquartered in San Mateo, California, and its shares are listed on the NASDAQ.